國立虎尾科技大學 |

Molecular Basis and Emerging Strategies for Anti-aging Interventions

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Molecular Basis and Emerging Strategies for Anti-aging Interventions/ edited by Syed Ibrahim Rizvi, Ufuk Çakatay.
其他作者:	Rizvi, Syed Ibrahim.
面頁冊數:	XIV, 386 p. 67 illus., 34 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Human physiology. -
電子資源:	https://doi.org/10.1007/978-981-13-1699-9
ISBN:	9789811316999

Molecular Basis and Emerging Strategies for Anti-aging Interventions
Molecular Basis and Emerging Strategies for Anti-aging Interventions[electronic resource] /edited by Syed Ibrahim Rizvi, Ufuk Çakatay. - 1st ed. 2018. - XIV, 386 p. 67 illus., 34 illus. in color.online resource.

Chapter 1. Hormesis and Hormetic drugs for healthy ageing and longevity -- Chapter 2. Intermittent fasting dietary restriction as a geroprotector.-Chapter 3. Anti-aging properties of Mediterranean diet components in human -- Chapter 4. Activation of plasma membrane redox system: A novel anti-aging strategy -- Chapter 5. Beneficial effects of alternate-day fasting and calorie restriction on the risk factors for age related diseases.-Chapter 6. Role of phytochemicals in eliciting longevity genes -- Chapter 7. Autophagy induction: A promising anti-aging strategy -- Chapter 8. The potential role of stem cell reprogramming in anti-aging -- Chapter 9. Anti-aging strategies based on telomerase activity -- Chapter 10. Epigenetic modification is an attractive target for therapeutic anti-aging intervention -- Chapter 11. Antioxidants for health and longevity -- Chapter 12. Current approaches of anti-inflammatory dependent anti-aging strategies -- Chapter 13. Anti-aging therapeutics based on rapalogs and mTOR inhibitors Exercise-induced anti-aging mechanisms -- Chapter 14. AMPK activation: An emerging anti-aging strategy -- Chapter 15. Sirtuin activators and brain aging -- Chapter 16. Glycolytic inhibitors as tools for developing caloric restriction mimetics -- Chapter 17. Novel classification perspective of geroprotective and senolytic drugs as an anti-aging strategy -- Chapter 18. The place of geroprotective agents in life quality and longevity of companion animals -- Chapter 19. Management of sarcopenia for successful aging -- Chapter 20. Impact of sarcopenia and sarcopenic obesity in healthy aging -- Chapter 21. Klotho levels may be an innovative approach for mitigating age-related diseases -- Chapter 22. Melatonin and its anti-aging activity. .

This book describes the nature of aging, age-related disorders, and the molecular principles of emerging strategies for anti-aging interventions, while also discussing the discovery of targets for geroprotective drugs. Although significant medical advances in the treatment and eradication of life-threatening conditions such as cardiovascular and infectious disease have been made over the past five decades, the prevalence of age-related disorders still remains high in older populations. Intervening into aging is the next frontier in contemporary medicine, and will be of increasing importance over time, as other sources of poor health are combated more and more successfully. Given the universal interest in anti-aging strategies, the book will appeal to a very broad audience. It addresses a diverse range of anti-aging interventions – including stem cells, autophagy, senolytics, anti-inflammatory methods, and telomerase induction – that will be of interest to scientists and researchers from various disciplines in the life sciences. .

ISBN: 9789811316999

Standard No.: 10.1007/978-981-13-1699-9doiSubjects--Topical Terms:

636012
Human physiology.

LC Class. No.: QP34-38

Dewey Class. No.: 612

Molecular Basis and Emerging Strategies for Anti-aging Interventions
LDR:04160nam a22003855i 4500 001 987058
003 DE-He213
005 20200629123915.0
007 cr nn 008mamaa
008 201225s2018 si | s |||| 0|eng d
020 $a 9789811316999 $9 978-981-13-1699-9
024 7 $a 10.1007/978-981-13-1699-9 $2 doi
035 $a 978-981-13-1699-9
050 4 $a QP34-38
072 7 $a MFG $2 bicssc
072 7 $a MED075000 $2 bisacsh
072 7 $a MFG $2 thema
082 0 4 $a 612 $2 23
245 1 0 $a Molecular Basis and Emerging Strategies for Anti-aging Interventions $h [electronic resource] / $c edited by Syed Ibrahim Rizvi, Ufuk Çakatay.
250 $a 1st ed. 2018.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a XIV, 386 p. 67 illus., 34 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Hormesis and Hormetic drugs for healthy ageing and longevity -- Chapter 2. Intermittent fasting dietary restriction as a geroprotector.-Chapter 3. Anti-aging properties of Mediterranean diet components in human -- Chapter 4. Activation of plasma membrane redox system: A novel anti-aging strategy -- Chapter 5. Beneficial effects of alternate-day fasting and calorie restriction on the risk factors for age related diseases.-Chapter 6. Role of phytochemicals in eliciting longevity genes -- Chapter 7. Autophagy induction: A promising anti-aging strategy -- Chapter 8. The potential role of stem cell reprogramming in anti-aging -- Chapter 9. Anti-aging strategies based on telomerase activity -- Chapter 10. Epigenetic modification is an attractive target for therapeutic anti-aging intervention -- Chapter 11. Antioxidants for health and longevity -- Chapter 12. Current approaches of anti-inflammatory dependent anti-aging strategies -- Chapter 13. Anti-aging therapeutics based on rapalogs and mTOR inhibitors Exercise-induced anti-aging mechanisms -- Chapter 14. AMPK activation: An emerging anti-aging strategy -- Chapter 15. Sirtuin activators and brain aging -- Chapter 16. Glycolytic inhibitors as tools for developing caloric restriction mimetics -- Chapter 17. Novel classification perspective of geroprotective and senolytic drugs as an anti-aging strategy -- Chapter 18. The place of geroprotective agents in life quality and longevity of companion animals -- Chapter 19. Management of sarcopenia for successful aging -- Chapter 20. Impact of sarcopenia and sarcopenic obesity in healthy aging -- Chapter 21. Klotho levels may be an innovative approach for mitigating age-related diseases -- Chapter 22. Melatonin and its anti-aging activity. .
520 $a This book describes the nature of aging, age-related disorders, and the molecular principles of emerging strategies for anti-aging interventions, while also discussing the discovery of targets for geroprotective drugs. Although significant medical advances in the treatment and eradication of life-threatening conditions such as cardiovascular and infectious disease have been made over the past five decades, the prevalence of age-related disorders still remains high in older populations. Intervening into aging is the next frontier in contemporary medicine, and will be of increasing importance over time, as other sources of poor health are combated more and more successfully. Given the universal interest in anti-aging strategies, the book will appeal to a very broad audience. It addresses a diverse range of anti-aging interventions – including stem cells, autophagy, senolytics, anti-inflammatory methods, and telomerase induction – that will be of interest to scientists and researchers from various disciplines in the life sciences. .
650 0 $a Human physiology. $3 636012
650 0 $a Geriatrics. $3 645067
650 0 $a Aging. $3 559847
650 0 $a Human genetics. $3 596505
650 0 $a Stem cells. $3 679759
650 1 4 $a Human Physiology. $3 668349
650 2 4 $a Geriatrics/Gerontology. $3 673757
650 2 4 $a Human Genetics. $3 593893
650 2 4 $a Stem Cells. $3 782732
700 1 $a Rizvi, Syed Ibrahim. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1210157
700 1 $a Çakatay, Ufuk. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1279544
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811316982
776 0 8 $i Printed edition: $z 9789811317002
856 4 0 $u https://doi.org/10.1007/978-981-13-1699-9
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)